69 Best Startups in Cambridge to Watch in 2024

Quantum error correction solutions provider.

Total Raised: $117.78M

Last Funding: $18.66M (Series B)

Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.

Total Raised: $117.50M

Last Funding: $75.00M (Series C)

LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.

Total Raised: $43.00M

Last Funding: $43.00M (Series A)

Surgical robotic system for minimal access surgery.

Total Raised: $1115.57M

Last Funding: $20.30M (Series A)

Silicon-free chip maker.

Total Raised: $288.70M

Last Funding: $34.90M (Series C)

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

Total Raised: $36.94M

Last Funding: $24.00M (Series B)

AI-driven drug discovery platform for rare diseases.

Total Raised: $47.00M

Last Funding: $47.00M (Series C)

First & last mile logistics in cities.

Total Raised: $5.48M

Last Funding: $5.10M (Series A)

Cubic-GaN technology designed for efficient, low-cost LEDs leveraging proprietary intellectual property.

Total Raised: $2.54M

Last Funding: $1.94M (Seed)

AI-powered investment analytics platform.

Total Raised: $6.50M

Last Funding: $6.50M (Series A)

Small molecule neoantigen immuno-oncology therapies developer.

Total Raised: $12.17M

Last Funding: $12.17M (Series B)

Evoralis is a plastic-depolymerizing enzymes producer founded in 2021 by Liisa van Vliet , Josephin Holstein and Mariana Rangel Pereira.

Total Raised: $3.30M

Last Funding: $3.30M (Seed)

AI-powered mental health assessment platform.

Total Raised: $7.06M

Last Funding: $5.10M (Series A)

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

Total Raised: $13.66M

Last Funding: $0.66M (Unknown)

Pact is a biomaterials producer from natural collagen founded in 2020 by Yudí Ding .

Total Raised: $12.10M

Last Funding: $12.10M (Seed)

Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.

Total Raised: $16.00M

Last Funding: $16.00M (Seed)

AllFocal Optics is a nanophotonic lens technology developer for always-in-focus images founded in 2022 by Pawan Shrestha .

Total Raised: $5.60M

Last Funding: $5.60M (Seed)

Sustainable cement producer.

Total Raised: $2.95M

Last Funding: $2.95M (Seed)

Digital platform for creating and delivering scents.

Total Raised: $2.90M

Last Funding: $2.90M (Series A)

Bluetooth low energy technology provider for IoT connectivity.

Total Raised: $4.60M

Last Funding: $4.60M (Seed)

Clock.bio is a novel treatments provider to increase human healthspan founded in 2020 by Joana Tavares .

Total Raised: $5.30M

Last Funding: $5.30M (Series A)

Climate analytics and risk assessement.

Total Raised: $34.25M

Last Funding: $26.00M (Series B)

AI-driven visual content moderation platform.

Total Raised: $16.50M

Last Funding: $1.50M (Seed)

Anti-cancer drug developer.

Total Raised: $28.00M

Last Funding: $28.00M (Series A)

Charging solutions for electric vehicles, including maintenance services.

Total Raised: $237.28M

Last Funding: $231.29M (Series C)

DNA synthesis technology researcher.

Total Raised: $24.00M

Last Funding: $24.00M (Series B)

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

Total Raised: $36.92M

Last Funding: $18.19M (Unknown)

Telecommunications company developing end-to-end quantum cryptography systems.

Total Raised: $7.00M

Last Funding: $7.00M (Seed)

Platform enabling the development of cell therapies through advanced reprogramming techniques.

Total Raised: $13.70M

Last Funding: $10.00M (Series A)

Platform for understanding and defining the biological codes that make up human cells.

Total Raised: $144.50M

Last Funding: $103.00M (Series B)

Software offering autonomous speech and voice recognition for live and recorded media.

Total Raised: $70.02M

Last Funding: $62.00M (Unknown)

Uncommon, formerly known as Higher Steaks, is a cellular agriculture company based in London, England founded in 2017 by Benjamina Bollag, Stephanie Wallis and David Hay working to develop pork and other meat products using cellular agriculture.

Total Raised: $30.00M

Last Funding: $30.00M (Series A)

Semiconductor developer.

Total Raised: $10.35M

Last Funding: $8.28M (Series A)

Pet therapeutics startup dedicated to developing medicines for pets.

Total Raised: $50.00M

Last Funding: $37.00M (Series B)

Smartphone imaging technology.

Total Raised: $48.68M

Last Funding: $40.48M (Series B)

Independent biotech company focused on developing new cancer therapies targeting DNA damage response.

Total Raised: $152.70M

Last Funding: $152.70M (Series C)

Gallium Nitride material technology developer.

Total Raised: $21.86M

Last Funding: $20.00M (Series A)

Provider of SITESEEKER platform for discovering new drugs.

Total Raised: $64.80M

Last Funding: $46.00M (Series B)

The food chain is broken. Our technology fixes it.

Total Raised: $19.79M

Last Funding: $16.00M (Series A)

Genomic data analysis platform.

Total Raised: $2.20M

Last Funding: $2.20M (Seed)

Human microbiome therapeutics developer creating live bacterial treatments and biomarkers.

Total Raised: $66.55M

Last Funding: $66.55M (Unknown)

Deubiquitylating enzyme (DUB) drug discovery and development platform.

Total Raised: $107.70M

Last Funding: $25.40M (Series B)

Decentralized network.

Total Raised: $45.00M

Last Funding: $40.00M (Series B)

Drug manufacturer.

Total Raised: $20.00M

Last Funding: $10.00M (Series A)

Fibroblast technology designed to develop new therapies for diseases.

Total Raised: $56.00M

Last Funding: $45.00M (Unknown)

Superfast-charging Li-ion batteries for various applications.

Total Raised: $38.85M

Last Funding: $36.90M (Series B)

Transforming mental healthcare by unlocking the power of clinical data

Total Raised: $52.62M

Last Funding: $52.62M (Series B)

Breathalyzer technology for non-invasive detection of infectious diseases.

Total Raised: $57.87M

Last Funding: $57.87M (Series D)

Cybersecurity platform providing cloud-native logging and security analytics for organizations.

Total Raised: $100.00M

Last Funding: $100.00M (Unknown)

Setting the standard for Salesforce DevOps

Total Raised: $55.00M

Last Funding: $55.00M (Unknown)

Quantum computing platform designed to solve complex computational problems.

Total Raised: $9.00M

Last Funding: $9.00M (Unknown)

Manufacturer of autonomous harvesting robots.

Total Raised: $1.90M

Last Funding: $1.90M (Seed)

Genomics company building safer cell and gene therapies.

Total Raised: $15.00M

Last Funding: $15.00M (Series A)

Drug delivery platform.

Total Raised: $24.47M

Last Funding: $24.47M (Series A)

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Total Raised: $88.00M

Last Funding: $88.00M (Series D)

Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.

Total Raised: $56.00M

Last Funding: $56.00M (Series B)

Transistors designed to integrate GaN technology into everyday consumer electronics.

Total Raised: $28.50M

Last Funding: $19.00M (Unknown)

Treatment for patients with chronic wounds.

Total Raised: $34.13M

Last Funding: $13.36M (Series B)

Supplier of configurable process node agnostic analog IP building blocks.

Total Raised: $24.04M

Last Funding: $19.00M (Series A)

Focal Point has developed next generation navigation and positioning software for smartphones, wearables and autonomous vehicles.

Total Raised: $34.83M

Last Funding: $26.49M (Series C)

Platform for AI developers to create dependable vision systems.

Total Raised: $3.52M

Last Funding: $3.40M (Seed)

Plant-based biodegradable material producer.

Total Raised: $9.49M

Last Funding: $2.50M (Seed)

Social multi-player gaming studio.

Total Raised: $7.00M

Last Funding: $4.00M (Series A)

Imaging analytics platform that processes and analyzes medical images.

Total Raised: $9.11M

Last Funding: $8.47M (Series A)

CQCL develops tools for the commercialisation of quantum computers by understanding quantum protocols and also quantum algorithms.

Total Raised: $45.00M

Last Funding: $45.00M (Unknown)

Cancer diagnostics.

Total Raised: $22.21M

Last Funding: $5.41M (Unknown)

Platform for identifying and sourcing specialist expertise globally using AI technology.

Total Raised: $16.93M

Last Funding: $12.00M (Series B)

Novel cancer therapies.

Total Raised: $30.00M

Last Funding: $30.00M (Series B)

GenAI-driven search engine for new materials.

Total Raised: $30.00M

Last Funding: $30.00M (Seed)